Research output per year
Research output per year
Research Output
- 1 - 50 out of 1,415 results
Search results
-
2025
Abstract P004: Mapping the tumor-sentinel node immune migratome demonstrates a key role for CCR7+ dendritic cells in the successful response to immunoradiotherapy
Saddawi-Konefka, R., Jensen, S. M., Fox, B. A., Bell, R. B. & comments, S. F. L. O. A. I., Jan 26 2025Research output: Other contribution
-
Adding New Agents to Treatment Protocols for Patients with CKD
Tuttle, K., Jan 1 2025Research output: Other contribution
-
Adoptive T-cell therapy against cancer using tumor-infiltrating lymphocytes (TIL) and gene engineered T cells
Tran, E., Feb 20 2025Research output: Other contribution
-
A New Risk Assessment Scale for Pressure Injuries in the ICU: The M.D.R. Scale
Murdock, A., Daily, A., Reilly, D. & Chiu, S.-T., Jan 1 2025Research output: Other contribution
File -
Bridging the Gap: A New Approach to Retaining ICU Nurses in Their First Year
Jones, M., Mayberry, K. & Sumner, S., Mar 7 2025Research output: Other contribution
File1 Downloads (Pure) -
Effects of Clinical Nursing Protocol on Intravenous Piggyback Infusion (IVPB) Practice
Smith, K., Doucette, S., Miller, T., Sloane, D., Delawska-Elliott, B. & Simanonok, M. P., Mar 7 2025Research output: Other contribution
File -
Evidence-based practice competencies, beliefs, and organizational readiness: A cross-sectional study
Timmerman, R., Gallegos, C., Saul, T. & Chu, F., Mar 7 2025Research output: Other contribution
-
Factors Related to Intent to Stay Among Acute Care Health Professionals
Stengem, D., Smock, A., Kopp, D. & Colorafi, K., Jan 1 2025Research output: Other contribution
-
GLP 1 Receptor Agonism FLOWS into the Mainstream for Chronic Kidney Disease
Tuttle, K., Jan 1 2025Research output: Other contribution
-
"I'll Be There For You"- FRIENDS and Spirituality May Impact Intent to Stay
Stengem, D., Smock, A., Doherty, A., Kopp, D. & Colorafi, K., Jan 1 2025Research output: Other contribution
-
Implementation of a Code Sepsis Response Protocol in a Large Emergency Department Increases Rate of Timely Antibiotic Administration in Patients with Suspected Sepsis
Shults, L., Cox, K., Kramer, D., Mariano, G., Pinkos, A., Sanders, J. & Patterson, K., Jan 1 2025Research output: Other contribution
File -
Increasing Special Pathogen Preparedness at a Frontline Hospital: A Quality Improvement Project
Freed, M., Arguinchona, C. & Bennett-Wolcott, B., Jan 1 2025Research output: Other contribution
File2 Downloads (Pure) -
Interview with Katherine Tuttle and Jonathan Barratt
Tuttle, K., Mar 1 2025Research output: Other contribution
-
Introducing the Divisional Nurse Scientists
Gallegos, C., Robinson, M. & Saul, T., Mar 7 2025Research output: Other contribution
-
Library Services and Digital Commons
Martin, H. & Schwartz, A., Mar 7 2025Research output: Other contribution
-
Outcomes of Critical Limb Threatening Ischemia Revascularization in Patients with Chronic Kidney Disease in the BEST - CLI Trial
Tuttle, K., Jan 1 2025Research output: Other contribution
-
Should ADCs Replace Docetaxel in 2L NSCLC
Sanborn, R., Feb 20 2025Research output: Other contribution
-
-
Unravelling the complexity of the anti-tumor response in human solid tumors
Duhen, T., Jan 16 2025Research output: Other contribution
-
Welcome & Reflection
Gallegos, C., Timmerman, R. & Halvor, S., Mar 7 2025Research output: Other contribution
-
“Celebrating Dr. Steven Packer with those who know him well”
Tuttle, K., Mar 1 2025Research output: Other contribution
-
“Diabetes and Kidneys: Unraveling T2D’s Silent Threat”
Alicic, R., Jan 1 2025Research output: Other contribution
-
“Goal for Saving Kidneys, Hearts and Lives”
Tuttle, K., Mar 1 2025Research output: Other contribution
-
“Most-cited paper – Prescription of guideline-directed medical therapies in patients with diabetes and chronic kidney disease from the CURE-CKD Registry, 2019-2020.”
Tuttle, K., Mar 1 2025Research output: Other contribution
-
2024
379. SGLT Inhibitors: The Biology of SGLT Inhibition with Dr. Katherine Tuttle
Tuttle, K., Aug 1 2024Research output: Other contribution
-
5th Designation Magnet Site Visit-Escape Room Activity
Rossillo, K. N., Nov 18 2024Research output: Other contribution
-
7P Patient-relevant endpoints from PAPILLON: Amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated (Ex20ins) advanced NSCLC
Paz-Ares, L., Sanborn, R. E. & comments, S. F. L. O. A. I., Mar 1 2024Research output: Other contribution
-
Acute Care Staff Interactions with Chaplains to Discuss Team or Personal, Non-work-related Stressors
Weisbrich, G., Sumner, S. & Rangel, T., Mar 1 2024Research output: Other contribution
File9 Downloads (Pure) -
Addressing unmet needs with aortic stenosis—How industry collaborations can improve care gaps
Gluckman, T. J., Jul 1 2024Research output: Other contribution
-
Adoptive cell therapy targeting mutations in gastrointestinal cancers
Tran, E., Jul 1 2024Research output: Other contribution
-
Advocating for things all professionals need: Fair pay, benefits, and job satisfaction
Gluckman, T. J., Apr 1 2024Research output: Other contribution
-
Alleviating Health Professionals' Moral Distress through Hospital-based Chaplain Care
Colorafi, K., Sumner, S. & Rangel, T., Mar 1 2024Research output: Other contribution
File9 Downloads (Pure) -
ALLO-316 in patients with advanced or metastatic clear cell renal cell carcinoma (ccRCC): updated safety and efficacy from the phase 1 TRAVERSE multicenter study
Srour, S., Curti, B. & comments, S. F. L. O. A. I., Nov 1 2024Research output: Other contribution
-
-
An open-label, phase 1, multicenter study to evaluate the safety and preliminary anti-tumor activity of NT-112 in human leukocyte antigen-C*08:02–positive adult patients with unresectable, advanced, and/or metastatic solid tumors that are positive for the KRAS G12D mutation
Morelli, M., Leidner, R. & comments, S. F. L. O. A. I., Jun 1 2024Research output: Other contribution
-
A phase 1, open-label, dose escalation study on the safety and tolerability of ANK-101 in advanced solid tumors
Park, J. C., Curti, B. & comments, S. F. L. O. A. I., Jun 1 2024Research output: Other contribution
-
A phase 1/1b study of the IL-2 prodrug WTX-124 in patients with locally advanced or metastatic solid tumors after checkpoint inhibitor therapy: Initial results of the combination dose escalation with pembrolizumab
Moser, J., Curti, B. & comments, S. F. L. O. A. I., Jun 1 2024Research output: Other contribution
-
A phase 1/2 trial in progress of MK-6070 (aka HPN328), a DLL3-targeting T cell engager, as monotherapy or combination therapy for advanced cancers associated with DLL3 expression
Jain, P., Sanborn, R. & comments, S. F. L. O. A. I., Nov 1 2024Research output: Other contribution
-
A phase-1 dose escalation and expansion study of EP0031, a next-generation selective RET inhibitor (SRI), in patients with SRI-naïve or pretreated advanced RET-altered NSCLC and other tumors
Garralda, E., Taylor, M. H. & comments, S. F. L. O. A. I., Jun 1 2024Research output: Other contribution
-
A phase1 study of autologous engineered CD4+ and CD8+ T cells, HLA-A*11:01-restricted, KRAS G12V-specific, transgenic TCR; CD8α/β coreceptor and a FAS41BB switch receptor in patients with solid tumors
Mitchell, S., Leidner, R. & comments, S. F. L. O. A. I., Nov 1 2024Research output: Other contribution
-
A phase 2a safety run-in and preliminary efficacy study of liposomal gemcitabine (FF-10832) in combination with pembrolizumab in patients with advanced solid tumors
Langer, C. J., Curti, B. & comments, S. F. L. O. A. I., Jun 1 2024Research output: Other contribution
-
Application of GigaPath: An open-weight billion-parameter AI foundation model based on a novel vision transformer architecture for cancer mutation prediction and TME analysis
Bifulco, C., Sep 1 2024Research output: Other contribution
-
A randomized phase II trial of adjuvant pembrolizumab versus observation following curative resection for stage I non-small cell lung cancer (NSCLC) with primary tumors between 1-4 cm: Big Ten Cancer Research Consortium BTCRC-LUN18-153
Durm, G., Sanborn, R. E. & comments, S. F. L. O. A. I., Jun 1 2024Research output: Other contribution
-
Artificial intelligence VS human pathology
Bifulco, C., Dec 1 2024Research output: Other contribution
-
-
A “SHIFT” in Behavioral Health Care: Putting Early Learnings into Action
Vartanian, K. B., Marsillo, R., Gronowski, B., Weller, M., Root, E., Raburn, B. & Kenton, N., Jan 1 2024Research output: Other contribution
File1 Downloads (Pure) -
-
Building the future: New Grad residency as a response to the staffing crisis
Silva, C. & Harmon, G., Mar 1 2024Research output: Other contribution
File6 Downloads (Pure) -
Building the future: New Grad Residency tactical expansion as a staffing crisis response
Silva, C. & Harmon, G., Apr 17 2024Research output: Other contribution
-
Cancer Dark Matter Vaccine: Clinical Responses
Leidner, R., Oct 1 2024Research output: Other contribution